On the horizon
After an eventful year, what’s next for the UK’s life sciences sector? Dr Kath MacKay looks into three areas for development in the years ahead
Read More
Search Results for: Dr Kath MacKay
RNA in the spotlight
RNA treatments and vaccines have just shown the scale of their potential. Now’s the time to position the UK as a global leader
Read More
April 2021
With the anchor now securely lodged in 2021, what’s on the horizon for the life sciences industry...
Read More
Transformational change
The decade ahead for UK pharma – a shot in the arm or bitter pill to swallow?
Innovate UK and Asthma UK to fund joint projects
Innovate UK and Asthma UK are joining forces to improve treatment for asthma.
Read More- 1
- 2
- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
